Brian J McMahon
Overview
Explore the profile of Brian J McMahon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
8015
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Said S, Shadaker S, McMahon B, Armstrong P, Beckett G, Kamili S, et al.
J Viral Hepat
. 2024 Dec;
32(1):e14051.
PMID: 39707980
Zanzibar, a low-resource semiautonomous region of Tanzania, has an estimated prevalence of hepatitis B virus (HBV) infections of 3.6%. To assess the feasibility of care and treatment, a 5-year hepatitis...
2.
McMahon B, Brown K, Herold C, Sawyer B
Phys Rev Lett
. 2024 Nov;
133(17):173201.
PMID: 39530822
We implement individual addressing and readout of ions in a rigidly rotating planar crystal in a compact, permanent magnet Penning trap. The crystal of ^{40}Ca^{+} is trapped and stabilized without...
3.
Bruden D, McMahon B, Snowball M, Towshend-Bulson L, Homan C, Johnston J, et al.
Hepatology
. 2023 Nov;
79(6):1412-1420.
PMID: 37939079
Background And Aims: A functional cure and therapeutic end point of chronic HBV infection is defined as the clearance of HBsAg from serum. Little is known about the long-term durability...
4.
McMahon B, Shrestha P, Thode Jr H, Morley E, Rao B, Tawfik G, et al.
Crit Pathw Cardiol
. 2023 May;
22(2):45-49.
PMID: 37220658
Objective: Emergency physicians are challenged to efficiently and reliably risk stratify patients presenting with chest pain (CP) to optimize diagnostic testing and avoid unnecessary hospital admissions. The objective of our...
5.
Jacobson I, Brown Jr R, McMahon B, Perrillo R, Gish R
J Clin Gastroenterol
. 2022 Apr;
56(6):478-492.
PMID: 35389923
The hepatitis B virus (HBV) is highly infectious, with over 292 million chronically infected people worldwide and up to 2.4 million in the United States. Following infection, clinically silent liver...
6.
Bruce M, Bruden D, Hurlburt D, Morris J, Bressler S, Thompson G, et al.
Hepatology
. 2022 Mar;
76(4):1180-1189.
PMID: 35320592
Background And Aims: The duration of protection from hepatitis B vaccination in children and adults is not known. In 1981, we used three doses of plasma-derived hepatitis B vaccine to...
7.
Bressler S, Bruden D, Nolen L, Bruce M, Towshend-Bulson L, Spradling P, et al.
Can J Gastroenterol Hepatol
. 2022 Feb;
2022():2573545.
PMID: 35178364
Background: Hepatitis C virus (HCV) infection incidence rates in the United States have increased since 2010 as a byproduct of the opioid crisis despite the introduction of direct-acting antiviral agents...
8.
Alvarez C, Petrick J, Parisi D, McMahon B, Graubard B, McGlynn K
Hepatology
. 2022 Feb;
76(3):589-598.
PMID: 35124828
Background And Aims: HCC is characterized by racial/ethnic disparities in rates. Recent USA reports suggest that incidence has begun to decline, but it is not clear whether the declines have...
9.
10.
Townshend-Bulson L, Roik E, Barbour Y, Bruden D, Homan C, Espera H, et al.
PLoS One
. 2021 Dec;
16(12):e0260970.
PMID: 34855920
Background: Direct-acting antiviral (DAA) drugs have been effective in the treatment of chronic hepatitis C virus (HCV) infection. Limited data are available on safety, tolerability, and efficacy in American Indian...